Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-84b7d79bbc-2l2gl Total loading time: 0 Render date: 2024-07-27T18:24:04.645Z Has data issue: false hasContentIssue false

37 - Gestational Trophoblastic Disease

from Section 5 - Gynecologic Oncology

Published online by Cambridge University Press:  01 February 2018

By
Lisa M. Barroilhet
Edited by
Lisa Keder  and
Martin E. Olsen
Lisa Keder
Affiliation:
Ohio State University
Martin E. Olsen
Affiliation:
East Tennessee State University
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Gynecologic Care , pp. 360 - 370
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bracken, M. B., Incidence and aetiology of hydatidiform mole: an epidemiological review. Br J Obstet Gynaecol, 1987. 94(12): p. 1123–35.CrossRefGoogle ScholarPubMed
Palmer, J. R., Advances in the epidemiology of gestational trophoblastic disease. J Reprod Med, 1994. 39(3): p. 155–62.Google Scholar
Berkowitz, R. S. et al., Risk factors for complete molar pregnancy from a case-control study. Am J Obstet Gynecol, 1985. 152(8): p. 1016–20.CrossRefGoogle ScholarPubMed
Parazzini, F. et al., Dietary factors and risk of trophoblastic disease. Am J Obstet Gynecol, 1988. 158(1): p. 93–9.Google Scholar
Parazzini, F. et al., Risk factors for gestational trophoblastic disease: a separate analysis of complete and partial hydatidiform moles. Obstet Gynecol, 1991. 78(6): p. 1039–45.Google ScholarPubMed
Berkowitz, R. S., Goldstein, D. P., and Bernstein, M. R., Evolving concepts of molar pregnancy. J Reprod Med, 1991. 36(1): p. 40–4.Google Scholar
Yamashita, K. et al., Human lymphocyte antigen expression in hydatidiform mole: androgenesis following fertilization by a haploid sperm. Am J Obstet Gynecol, 1979. 135(5): p. 597–600.CrossRefGoogle ScholarPubMed
Szulman, A. E. and Surti, U., The syndromes of hydatidiform mole. II. Morphologic evolution of the complete and partial mole. Am J Obstet Gynecol, 1978. 132(1): p. 20–7.Google Scholar
Berkowitz, R. S. and Goldstein, D. P., Gestational trophoblastic disease. Cancer, 1995. 76(10 Suppl): p. 2079–85.Google Scholar
Benson, C. B. et al., Sonographic appearance of first trimester complete hydatidiform moles. Ultrasound Obstet Gynecol, 2000. 16(2): p. 188–91.CrossRefGoogle ScholarPubMed
Romero, R. et al., New criteria for the diagnosis of gestational trophoblastic disease. Obstet Gynecol, 1985. 66(4): p. 553–8.Google ScholarPubMed
Genest, D. R. et al., A clinicopathologic study of 153 cases of complete hydatidiform mole (1980–1990): histologic grade lacks prognostic significance. Obstet Gynecol, 1991. 78(3 Pt 1): p. 402–9.Google ScholarPubMed
Menczer, J., Modan, M., and Serr, D. M., Prospective follow-up of patients with hydatidiform mole. Obstet Gynecol, 1980. 55(3): p. 346–9.Google Scholar
Soto-Wright, V. et al., The changing clinical presentation of complete molar pregnancy. Obstet Gynecol, 1995. 86(5): p. 775–9.Google ScholarPubMed
Muminhodzic, L. and Bogdanovic, G., Ultrasonographic signs of partial hydatidiform mole. Med Arch, 2013. 67(3): p. 205–8.CrossRefGoogle ScholarPubMed
Thaker, H. M. et al., Immunohistochemistry for the imprinted gene product IPL/PHLDA2 for facilitating the differential diagnosis of complete hydatidiform mole. J Reprod Med, 2004. 49(8): p. 630–6.Google Scholar
Sun, S. Y. et al., Changing presentation of complete hydatidiform mole at the New England Trophoblastic Disease Center over the past three decades: does early diagnosis alter risk for gestational trophoblastic neoplasia? Gynecol Oncol, 2015. 138(1): p. 46–9.CrossRefGoogle ScholarPubMed
Osathanondh, R. et al., Hormonal measurements in patients with theca lutein cysts and gestational trophoblastic disease. J Reprod Med, 1986. 31(3): p. 179–83.Google ScholarPubMed
Seckl, M. J., Sebire, N. J., and Berkowitz, R. S., Gestational trophoblastic disease. Lancet, 2010. 376(9742): p. 717–29.Google Scholar
Berkowitz, R. S. and Goldstein, D. P., Chorionic tumors. N Engl J Med, 1996. 335(23): p. 1740–8.Google Scholar
Elias, K. M., Goldstein, D. P., and Berkowitz, R. S., Complete hydatidiform mole in women older than age 50. J Reprod Med, 2010. 55(5–6): p. 208–12.Google ScholarPubMed
Orr, J. W., Jr. et al., Acute pulmonary edema associated with molar pregnancies: a high-risk factor for development of persistent trophoblastic disease. Am J Obstet Gynecol, 1980. 136(3): p. 412–5.CrossRefGoogle ScholarPubMed
Goldstein, D. P. and Berkowitz, R. S., Prophylactic chemotherapy of complete molar pregnancy. Semin Oncol, 1995. 22(2): p. 157–60.Google Scholar
Limpongsanurak, S., Prophylactic actinomycin D for high-risk complete hydatidiform mole. J Reprod Med, 2001. 46(2): p. 110–6.Google Scholar
Uberti, E. M. et al., Prevention of postmolar gestational trophoblastic neoplasia using prophylactic single bolus dose of actinomycin D in high-risk hydatidiform mole: a simple, effective, secure and low-cost approach without adverse effects on compliance to general follow-up or subsequent treatment. Gynecol Oncol, 2009. 114(2): p. 299–305.Google Scholar
Curry, S. L. et al., Hydatidiform mole: diagnosis, management, and long-term followup of 347 patients. Obstet Gynecol, 1975. 45(1): p. 1–8.Google Scholar
Wolfberg, A. J. et al., Low risk of relapse after achieving undetectable HCG levels in women with partial molar pregnancy. Obstet Gynecol, 2006. 108(2): p. 393–6.Google Scholar
Kohorn, E. I., Persistent low-level “real” human chorionic gonadotropin: a clinical challenge and a therapeutic dilemma. Gynecol Oncol, 2002. 85(2): p. 315–20.Google Scholar
Curry, S. L. et al., Hormonal contraception and trophoblastic sequelae after hydatidiform mole (a Gynecologic Oncology Group Study). Am J Obstet Gynecol, 1989. 160(4): p. 805–9 (809–11).Google Scholar
Berkowitz, R. S. et al., Oral contraceptives and postmolar trophoblastic disease. Obstet Gynecol, 1981. 58(4): p. 474–7.Google Scholar
Costa, H. L. and Doyle, P., Influence of oral contraceptives in the development of post-molar trophoblastic neoplasia: a systematic review. Gynecol Oncol, 2006. 100(3): p. 579–85.CrossRefGoogle ScholarPubMed
Gaffield, M. E., Kapp, N., and Curtis, K. M., Combined oral contraceptive and intrauterine device use among women with gestational trophoblastic disease. Contraception, 2009. 80(4): p. 363–71.Google Scholar
Pezeshki, M., B. W. Hancock, P. Silcocks, J. E. Everard, J. Coleman, A. M. Gillespie, J. Tidy, R. E. Coleman, The role of repeat uterine evacuation in the management of persistent gestational trophoblastic disease. Gynecol Oncol, 2004. 95(3): p. 423–9.Google Scholar
Dobson, L. S. et al., The presentation and management of post-partum choriocarcinoma. Br J Cancer, 1999. 79(9–10): p. 1531–3.CrossRefGoogle ScholarPubMed
Milenkovic, V. and Lazovic, B., Pulmonary metastasis in patients with gestational trophoblastic disease. Int J Gynaecol Obstet, 2011. 112(2): p. 145.CrossRefGoogle ScholarPubMed
Berry, E., Hagopian, G. S., and Lurain, J. R., Vaginal metastases in gestational trophoblastic neoplasia. J Reprod Med, 2008. 53(7): p. 487–92.Google Scholar
Cagayan, M. S., Vaginal metastases complicating gestational trophoblastic neoplasia. J Reprod Med, 2010. 55(5–6): p. 229–35.Google ScholarPubMed
Newlands, E. S. et al., Management of brain metastases in patients with high-risk gestational trophoblastic tumors. J Reprod Med, 2002. 47(6): p. 465–71.Google Scholar
Gillespie, A. M. et al., Placental site trophoblastic tumour: a rare but potentially curable cancer. Br J Cancer, 2000. 82(6): p. 1186–90.Google Scholar
Berkowitz, R. S., Goldstein, D. P., and Bernstein, M. R., Modified triple chemotherapy in the management of high-risk metastatic gestational trophoblastic tumors. Gynecol Oncol, 1984. 19(2): p. 173–81.CrossRefGoogle ScholarPubMed
Alazzam, M. P. et al., First-line chemotherapy in low-risk gestational trophoblastic neoplasia, Cochrane Database Syst Rev, 2012. 7: p. CD007102.Google Scholar
Shah, N. T. et al., A cost analysis of first-line chemotherapy for low-risk gestational trophoblastic neoplasia. J Reprod Med, 2012. 57(5–6): p. 211–8.Google Scholar
Sekharan, P. K. et al., Management of postmolar gestational trophoblastic disease with methotrexate and folinic acid: 15 years of experience. J Reprod Med, 2006. 51(10): p. 835–40.Google Scholar
Feldman, S., Goldstein, D. P., and Berkowitz, R. S., Low-risk metastatic gestational trophoblastic tumors. Semin Oncol, 1995. 22(2): p. 166–71.Google Scholar
Newlands, E. S. et al., Management of resistant gestational trophoblastic tumors. J Reprod Med, 1998. 43(2): p. 111–8.Google ScholarPubMed
Bagshawe, K. D., Treatment of high-risk choriocarcinoma. J Reprod Med, 1984. 29(11): p. 813–20.Google ScholarPubMed
Evans, A. C., Jr. et al., Gestational trophoblastic disease metastatic to the central nervous system. Gynecol Oncol, 1995. 59(2): p. 226–30.Google Scholar
Cole, L. A., Phantom hCG and phantom choriocarcinoma. Gynecol Oncol, 1998. 71(2): p. 325–9.Google Scholar
Cole, L. A., hCG, its free subunits and its metabolites: roles in pregnancy and trophoblastic disease. J Reprod Med, 1998. 43(1): p. 3–10.Google ScholarPubMed
Goldstein, D. P., Zanten-Przybysz, I., Bernstein, M. R., Berkowitz, R. S., Revised FIGO staging system for gesational trophoblastic tumors; recommendations regarding therapy. J Reprod Med, 1998. 43: p. 27–43.Google Scholar
Berkowitz, R. S. and Goldstein, D. P., Current management of gestational trophoblastic diseases. Gynecol Oncol 2009;112: p. 654–62.Google Scholar
Matsui, H., Iitsuka, Y., Suzuka, K et al., Early pregnancy outcomes after chemotherapy for gestational trophoblastic tumor. J Reprod Med 2004;49:531–4.Google ScholarPubMed
Garrett, L.A. et al., Subsequent pregnancy outcomes in patients with molar pregnancy and persistent gestational trophoblastic neoplasia. J Reprod Med, 2008. 53(7): p. 481–6.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×